Renan César Sbruzzi

Dr. Renan César Sbruzzi

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2022 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
LSLuís Fernando Castagnino Sesti
Luís Fernando Castagnino Sesti
RSRenan César Sbruzzi
Renan César Sbruzzi
EPEvelise Regina Polina
Evelise Regina Polina
DSDOUGLAS DOS SANTOS SOARES
DOUGLAS DOS SANTOS SOARES
DCDaisy Crispim
Daisy Crispim
KSKátia Gonçalves dos Santos
Kátia Gonçalves dos Santos
Background: Diabetic retinopathy (DR) is characterized by ischemia, hypoxia, and angiogenesis. Erythropoietin (EPO), an angiogenic hormone, is upregulated in DR, and the association of EPO genetic variants with DR is still uncertain, as conflicting results have been reported. Therefore, we performed a case–control study followed by a meta-analysis to investigate whether the rs1617640, rs507392, and rs551238 polymorphisms in EPO gene are associated with DR. Methods: The case–control study included 1042 Southern Brazilians with type 2 diabetes (488 without DR and 554 with DR). Eligible studies for the meta-analysis were searched from electronic databases up to June 1, 2021. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were estimated for five genetic inheritance models. Results: The minor alleles of the EPO polymorphisms had nearly the same frequency in all groups of patients (35%), and no association was detected with DR in the case–control study. The meta-analysis included 14 independent sets of cases and controls with 9117 subjects for the rs1617640 polymorphism and nine independent sets with more than 5000 subjects for the rs507392 and rs551238 polymorphisms. The G allele of the rs1617640 polymorphism was suggestively associated with DR under the dominant (OR = 0.82, 95% CI: 0.68–0.98), heterozygous additive (OR = 0.82, 95% CI: 0.69–0.97), and overdominant (OR = 0.88, 95% CI: 0.79–0.97) models. In the subgroup analyses, the G allele was also suggestively associated with proliferative DR (PDR), non-proliferative DR (NPDR), and DR (PDR + NPDR) among patients with type 1 diabetes (T1DM) or non-Asian ancestry. After considering the Bonferroni correction for multiple comparisons, the G allele remained associated with NPDR and DR in T1DM. Regarding the rs507392 and rs551238 polymorphisms, no association was found between these variants and DR. Conclusion: Our findings provide additional support to EPO as a susceptibility gene for DR, with the rs1617640 polymorphism deserving further investigation.

19 September 2024 in Molecular Biotechnology
Verified
Journal Article
Closed access
PDF file
MMMarcela Marmitt
Marcela Marmitt
GCGuilherme Pinto Cauduro
Guilherme Pinto Cauduro
RSRenan César Sbruzzi
Renan César Sbruzzi
Victor ValiatiVictor Valiati
Victor Valiati